Global Earnings in Focus Wednesday: HSBC, UBS, Porsche, Hermès -- WSJ

Dow Jones
2025/07/30

By WSJ Staff

HSBC $(HSBC)$: The Asia-focused bank reported a drop in quarterly profit, partly due to $2.1 billion of losses related to its stake in Chinese lender Bank of Communications (CN:601328). HSBC shares sold off in London.

UBS (UBS): The Swiss bank's quarterly profit more than doubled on the year, as market volatility boosted its revenue from trading and investment banking. Shares rose in Zurich.

Nissan Motor (JP:7201): The Japanese automaker reported a loss for a fourth consecutive quarter, as it takes steps to reverse falling sales. Shares fell 1.6%.

Hermès (FR:RMS): The Birkin bag maker's sales accelerated last quarter, despite the slowdown in luxury demand. But Hermès flagged uncertain geopolitics, and its first-half net profit fell. Shares fell as much as 4%.

Mercedes-Benz (XE:MBG): The German car maker warned that revenue will be significantly lower than last year due to tariffs hitting sales. The U.S.-European Union trade deal struck Sunday will see a 15% levy on EU car exports. Mercedes-Benz shares fell 1.4%.

Porsche (XE:P911): The German luxury automaker also cut annual forecasts to reflect the trade agreement. However, its first-half results largely topped forecasts, and shares gained 3%.

Adidas (XE:ADS): The sporting-goods company posted lower-than-expected sales and flagged uncertainty around the impact from U.S. tariffs. Shares tumbled 7%.

Novo Nordisk $(NVO.AU)$: Shares in the Danish drugmaker slipped early Wednesday, extending a slide on Tuesday after it slashed its profit and revenue forecasts.

This item is part of a Wall Street Journal live coverage event. The full stream can be found by searching P/WSJL (WSJ Live Coverage).

(END) Dow Jones Newswires

July 30, 2025 06:26 ET (10:26 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10